Cipher Pharmaceuticals is a specialty pharmaceutical company that offers a wide range of commercial and early to late-stage products. With a robust and diversified portfolio, Cipher focuses on acquiring products that address unmet medical needs. They oversee the entire clinical development and regulatory approval process of these products and market them directly in Canada.

Furthermore, Cipher collaborates with partners in the U. S. The company operates with a lean corporate structure and establishes strategic operational partnerships.

They also in-license and out-license products while making selective investments in drug development. This approach allows Cipher to assemble a broad portfolio of prescription products. For more information, you can visit their website and view their latest presentation.

Cipher Pharmaceuticals is committed to providing innovative solutions that meet the needs of patients worldwide